The Patent Finder

Servicio Andaluz de Salud

11 patents currently held · Updated Nov 18, 2026
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 1, 2027
    The maintenance fee for Use of a composition comprising a poly-organosiloxane (US 9,119,873) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
  • 1 fee due May 5, 2027
    The maintenance fee for Use of non-peptide NK1 antagonists in a predetermined dose for the treatment of cancer (US 10,463,670) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,119,873Use of a composition comprising a poly-organosiloxane
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,463,670Use of non-peptide NK1 antagonists in a predetermined dose for the treatment of cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,344,531Durable preparation of an injectable of melatonin exhibiting long-term stability
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,960,011Compositions for the treatment of ischemic ulcers and stretch marks
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,869,886Cell Suspension for Use in the Treatment of Lower Extremity Peripheral Artery Disease
In force
 · High confidence
In forceHigh confidence
US 11,344,260Predicting the risk of death or vasospasm in a patient with a subarachnoid hemorrhage
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,565,019Hemostatic Efficacy of a Nanostructured Fibrin Agarose Hydrogel
In force
 · High confidence
In forceHigh confidence
US D1,154,972Fixation Device for Medical Tubes
In force
 · High confidence
In forceHigh confidence
US 12,245,623Olive oil enriched with oleanolic acid, process for its preparation and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,611,346Anti-Bedsore Device
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 5 patents in force now held by others · 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

8 pending · 8 abandoned · 46 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited